The Pharmaceutical Journal
Vol 279 No 7474 432
20 October 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Oestrogen receptor modulator reduces vertebral fractures

Bazedoxifene, a selective oestrogen receptor modulator, reduces occurrence of new vertebral fractures in postmenopausal women at high risk of fractures, the results of a study presented at the American Society for Bone and Mineral Research meeting in Hawaii last month showed.